Eli Lilly Says Phase 3 Results In Flortaucipir PET Imaging Agent Showed That Flortaucipir Demonstrated Statistically Significant Sensitivity And specificity For Detecting A High Level Of Total Alzheimer's Disease Neuropathologic Change
Benzinga_Newsdesk